トップ > 製品検索結果一覧
MHCテトラマー（270）
| クリップ | Code No. | 品名 | データ | ||||
|---|---|---|---|---|---|---|---|
| データ
シート |
項目 | 標識 | MHC Allele | 包装 | 価格 | 在庫 | |
| 配列 | 位置 | 温度 | |||||
|
|
|||||||
|
TS-M014-1 |
T-Select HLA-A*24:02 modified WT1 Tetramer-CYTWNQMNL-PE |
|
||||
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| CYTWNQMNL | 235-243 | 4°C | |||||
|
|
TB-M011-1 |
T-Select HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLLMWITQC | 157-165 | 4°C | |||||
|
|
TS-M705-1 |
I-Ab FMLV123-141 Tetramer-PE |
|
||||
|
|
cancer | PE | I-Ab | 20 tests | ￥198,000 |
0 (お問合せ） |
|
| EPLTSLTPRCNTAWNRLKL | 123-141 | 4°C | |||||
|
|
TS-M505-1 |
T-Select H-2Db human gp100 Tetramer-KVPRNQDWL-PE |
|
||||
|
|
cancer | PE | H-2Db | 50 tests | ￥209,000 | 1-9 | |
| KVPRNQDWL | 25-33 | 4°C | |||||
|
|
TS-M025-1 |
T-Select HLA-A*24:02 survivin-2B Tetramer-AYACNTSTL-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 | 1-9 | |
| AYACNTSTL | 80-88 | 4°C | |||||
|
|
TS-M546-1 |
H-2Db gp100 Tetramer-EGSRNQDWL-PE |
|
||||
|
|
cancer | PE | H-2Db | 50 tests | ￥209,000 | 1-9 | |
| EGSRNQDWL | 25-33 | 4°C | |||||
|
|
TB-0009-1 |
T-Select HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ELAGIGILTV | 26-35 | 4°C | |||||
|
|
TB-5004-2 |
T-Select H-2Kb TRP-2 Tetramer-SVYDFFVWL-APC |
|
||||
| cancer | APC | H-2Kb | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SVYDFFVWL | 180-188 | 4°C | |||||
|
|
TS-M016-1 |
T-Select HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| RMFPNAPYL | 126-134 | 4°C | |||||
|
|
TS-M504-1 |
T-Select H-2Db WT1 Tetramer-RMFPNAPYL-PE |
|
||||
|
|
cancer | PE | H-2Db | 50 tests | ￥209,000 | 1-9 | |
| RMFPNAPYL | 126-134 | 4°C | |||||
|
|
TB-5004-1 |
T-Select H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE |
|
||||
| cancer | PE | H-2Kb | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SVYDFFVWL | 180-188 | 4°C | |||||
|
|
TS-M140-1 |
HLA-A*02:01 WT137-45 Tetramer-VLDFAPPGA-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| VLDFAPPGA | 37-45 | 4°C | |||||
|
|
TS-M085-1 |
HLA-A*02:01 Survivin (T2M) Tetramer-LMLGEFLKL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| LMLGEFLKL | 96-104 | 4°C | |||||
|
|
TB-0009-2 |
T-Select HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ELAGIGILTV | 26-35 | 4°C | |||||
|
|
TB-M011-2 |
T-Select HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLLMWITQC | 157-165 | 4°C | |||||
|
|
TS-M118-1 |
HLA-A*02:01 PRAME425-433 Tetramer-SLLQHLIGL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| SLLQHLIGL | 425-433 | 4°C | |||||
|
|
TS-M118-2 |
HLA-A*02:01 PRAME425-433 Tetramer-SLLQHLIGL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| SLLQHLIGL | 425-433 | 4°C | |||||
|
|
TS-M104-1 |
HLA-A*02:01 RHAMM Tetramer-ILSLELMKL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| ILSLELMKL | 165-173 | 4°C | |||||
|
|
TS-M504-2 |
T-Select H-2Db WT1126-134 Tetramer-RMFPNAPYL-APC |
|
||||
|
|
cancer | APC | H-2Db | 50 tests | ￥209,000 | 1-9 | |
| RMFPNAPYL | 126-134 | 4°C | |||||
|
|
TS-M102-2 |
HLA-A*02:01 CD33 A65Y Tetramer-YIISGDSPV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YIISGDSPV | 65-73 | 4°C | |||||
|
|
TS-M087-1 |
HLA-A*02:01 PSA Tetramer-KLQCVDLHV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| KLQCVDLHV | 146-154 | 4°C | |||||
|
|
TS-M103-1 |
HLA-A*02:01 CEA Tetramer-YLSGANLNL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| YLSGANLNL | 605-613 | 4°C | |||||
|
|
TB-M074-2 |
HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-APC |
|
||||
| cancer | APC | A*01:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| EVDPIGHLY | 168-176 | 4°C | |||||
|
|
TB-M082-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLEPGPVTA | 280-288 | 4°C | |||||
|
|
TB-M088-1 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| LLLLTVLTV | 12-20 | 4°C | |||||
|
|
TS-0019-2C |
T-Select HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YMDGTMSQV | 368-376 | 4°C | |||||
|
|
TS-M071-1 |
HLA-B*07:02 MAGE-A1 Tetramer-RVRFFFPSL-PE |
|
||||
|
|
cancer | PE | B*07:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| RVRFFFPSL | 289-297 | 4°C | |||||
|
|
TS-M114-2 |
HLA-A*01:01 MAGE-A1 Tetramer-EADPTGHSY-APC |
|
||||
|
|
cancer | APC | A*01:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EADPTGHSY | 161-169 | 4°C | |||||
|
|
TS-M117-1 |
HLA-A*02:01 PRAME100-108 Tetramer-VLDGLDVLL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| VLDGLDVLL | 100-108 | 4°C | |||||
|
|
TS-M140-2 |
HLA-A*02:01 WT137-45 Tetramer-VLDFAPPGA-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| VLDFAPPGA | 37-45 | 4°C | |||||
|
|
TB-M082-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLEPGPVTA | 280-288 | 4°C | |||||
|
|
TB-0013-2 |
T-Select HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| IMDQVPFSV | 209-217 | 4°C | |||||
|
|
TS-0019-1C |
T-Select HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YMDGTMSQV | 368-376 | 4°C | |||||
|
|
TS-M025-2 |
T-Select HLA-A*24:02 survivin-2B Tetramer-AYACNTSTL-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AYACNTSTL | 80-88 | 4°C | |||||
|
|
TS-M103-2 |
HLA-A*02:01 CEA Tetramer-YLSGANLNL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YLSGANLNL | 605-613 | 4°C | |||||
|
|
TS-M114-1 |
HLA-A*01:01 MAGE-A1 Tetramer-EADPTGHSY-PE |
|
||||
|
|
cancer | PE | A*01:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EADPTGHSY | 161-169 | 4°C | |||||
|
|
TS-M505-2 |
T-Select H-2Db human gp100 Tetramer-KVPRNQDWL-APC |
|
||||
|
|
cancer | APC | H-2Db | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| KVPRNQDWL | 25-33 | 4°C | |||||
|
|
TB-M105-1 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLLMWITQV | 157-165 | 4°C | |||||
|
|
TB-M074-1 |
HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-PE |
|
||||
| cancer | PE | A*01:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| EVDPIGHLY | 168-176 | 4°C | |||||
|
|
TS-M077-1 |
HLA-A*24:02 MAGE-A3 Tetramer-IMPKAGLLI-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| IMPKAGLLI | 195-203 | 4°C | |||||
|
|
TS-M080-1 |
HLA-A*02:01 CEA (N6D) Tetramer-YLSGADLNL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YLSGADLNL | 605-613 | 4°C | |||||
|
|
TS-M116-1 |
HLA-A*02:01 PRAME300-309 Tetramer-ALYVDSLFFL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| ALYVDSLFFL | 300-309 | 4°C | |||||
|
|
TB-M072-1 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLQLVFGIEV | 157-166 | 4°C | |||||
|
|
TS-M073-1 |
HLA-A*24:02 MAGE-A2 Tetramer-EYLQLVFGI-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EYLQLVFGI | 156-164 | 4°C | |||||
|
|
TS-M090-1 |
HLA-A*24:02 tyrosinase Tetramer-AFLPWHRLF-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AFLPWHRLF | 206-214 | 4°C | |||||
|
|
TS-M558-1 |
H-2Kb MAGE-AX169-176 Tetramer-LGITYDGM-PE |
|
||||
|
|
cancer | PE | H-2Kb | 50 tests | ￥209,000 | 1-9 | |
| LGITYDGM | 169-176 | 4°C | |||||
|
|
TS-M089-1 |
HLA-A*24:02 gp100-intron 4 Tetramer-VYFFLPDHL-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| VYFFLPDHL | 170-178 | 4°C | |||||
|
|
TS-M116-2 |
HLA-A*02:01 PRAME300-309 Tetramer-ALYVDSLFFL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| ALYVDSLFFL | 300-309 | 4°C | |||||
|
|
TS-M117-2 |
HLA-A*02:01 PRAME100-108 Tetramer-VLDGLDVLL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| VLDGLDVLL | 100-108 | 4°C | |||||
|
|
TS-M138-2 |
HLA-A*02:01 MAGE-C1 Tetramer-ILFGISLREV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| ILFGISLREV | 959-968 | 4°C | |||||
|
|
TB-0035-2 |
T-Select HLA-A*02:01 gp100 154-162-KTWGQYWQV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KTWGQYWQV | 154-162 | 4°C | |||||
|
|
TS-M080-2 |
HLA-A*02:01 CEA (N6D) Tetramer-YLSGADLNL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YLSGADLNL | 605-613 | 4°C | |||||
|
|
TS-M087-2 |
HLA-A*02:01 PSA Tetramer-KLQCVDLHV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| KLQCVDLHV | 146-154 | 4°C | |||||
|
|
TS-M101-1 |
HLA-A*02:01 CD33 Tetramer-AIISGDSPV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AIISGDSPV | 65-73 | 4°C | |||||
|
|
TS-M102-1 |
HLA-A*02:01 CD33 A65Y Tetramer-YIISGDSPV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YIISGDSPV | 65-73 | 4°C | |||||
|
|
TS-M104-2 |
HLA-A*02:01 RHAMM Tetramer-ILSLELMKL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| ILSLELMKL | 165-173 | 4°C | |||||
|
|
TS-M559-1 |
H-2Kb MAGE-A5 Tetramer-HNTQYCNL-PE |
|
||||
|
|
cancer | PE | H-2Kb | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| HNTQYCNL | 5-12 | 4°C | |||||
|
|
TB-M107-1 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ALDVYNGLL | 299-307 | 4°C | |||||
|
|
TB-M070-1 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KVLEYVIKV | 278-286 | 4°C | |||||
|
|
TB-0035-1 |
T-Select HLA-A*02:01 gp100 154-162-KTWGQYWQV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KTWGQYWQV | 154-162 | 4°C | |||||
|
|
TB-0016-2 |
T-Select HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RLLQETELV | 689-697 | 4°C | |||||
|
|
TB-M088-2 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| LLLLTVLTV | 12-20 | 4°C | |||||
|
|
TS-M138-1 |
HLA-A*02:01 MAGE-C1 Tetramer-ILFGISLREV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| ILFGISLREV | 959-968 | 4°C | |||||
|
|
TS-M558-2 |
H-2Kb MAGE-AX169-176 Tetramer-LGITYDGM-APC |
|
||||
|
|
cancer | APC | H-2Kb | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| LGITYDGM | 169-176 | 4°C | |||||
|
|
TS-M559-2 |
H-2Kb MAGE-A5 Tetramer-HNTQYCNL-APC |
|
||||
|
|
cancer | APC | H-2Kb | 50 tests | ￥209,000 | 1-9 | |
| HNTQYCNL | 5-12 | 4°C | |||||
|
|
TS-M010-1 |
T-Select HLA-A*24:02 hTERT Tetramer-VYGFVRACL-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| VYGFVRACL | 461-469 | 4°C | |||||
|
|
TS-M137-1 |
HLA-A*01:01 AIM-2 Tetramer-RSDSGQQARY-PE |
|
||||
|
|
cancer | PE | A*01:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| RSDSGQQARY | - | 4°C | |||||
|
|
TS-M141-2 |
HLA-A*24:02 ACC-1 Tetramer-DYLQYVLQI-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| DYLQYVLQI | 15-23 | 4°C | |||||
|
|
TB-M107-2 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ALDVYNGLL | 299-307 | 4°C | |||||
|
|
TB-M562-2 |
H-2Kb mTERT Tetramer-VGRNFTNL-APC |
|
||||
| cancer | APC | H-2Kb | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| VGRNFTNL | 198-205 | 4°C | |||||
|
|
TB-M072-2 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLQLVFGIEV | 157-166 | 4°C | |||||
|
|
TB-0015-1 |
T-Select HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KIFGSLAFL | 369-377 | 4°C | |||||
|
|
TS-M078-1 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| GLYDGMEHL | 254-262 | 4°C | |||||
|
|
TS-M085-2 |
HLA-A*02:01 Survivin (T2M) Tetramer-LMLGEFLKL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| LMLGEFLKL | 96-104 | 4°C | |||||
|
|
TS-M090-2 |
HLA-A*24:02 tyrosinase Tetramer-AFLPWHRLF-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AFLPWHRLF | 206-214 | 4°C | |||||
|
|
TS-M101-2 |
HLA-A*02:01 CD33 Tetramer-AIISGDSPV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AIISGDSPV | 65-73 | 4°C | |||||
|
|
TS-M119-1 |
HLA-A*02:01 PRAME142-151 Tetramer-SLYSFPEPEA-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| SLYSFPEPEA | 142-151 | 4°C | |||||
|
|
TS-M563-1 |
H-2Kb pBM1 Tetramer-INFDFNTI-PE |
|
||||
|
|
cancer | PE | H-2Kb | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| INFDFNTI | 207-214 | 4°C | |||||
|
|
TB-M120-2 |
HLA-A*02:01 PSA141-150 Tetramer-FLTPKKLQCV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLTPKKLQCV | 141-150 | 4°C | |||||
|
|
TS-M115-1 |
HLA-A*02:01 hTERT Tetramer-ILAKFLHWL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| ILAKFLHWL | 540-548 | 4°C | |||||
|
|
TS-M141-1 |
HLA-A*24:02 ACC-1 Tetramer-DYLQYVLQI-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| DYLQYVLQI | 15-23 | 4°C | |||||
|
|
TB-M105-2 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLLMWITQV | 157-165 | 4°C | |||||
|
|
TS-M109-1 |
HLA-B*07:02 P2X5 Tetramer-TPNQRQNVC-PE |
|
||||
|
|
cancer | PE | B*07:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TPNQRQNVC | 110-118 | 4°C | |||||
|
|
TS-M563-2 |
H-2Kb pBM1 Tetramer-INFDFNTI-APC |
|
||||
|
|
cancer | APC | H-2Kb | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| INFDFNTI | 207-214 | 4°C | |||||
|
|
TB-M562-1 |
H-2Kb mTERT Tetramer-VGRNFTNL-PE |
|
||||
| cancer | PE | H-2Kb | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| VGRNFTNL | 198-205 | 4°C | |||||
|
|
TB-0016-1 |
T-Select HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RLLQETELV | 689-697 | 4°C | |||||
|
|
TS-M137-2 |
HLA-A*01:01 AIM-2 Tetramer-RSDSGQQARY-APC |
|
||||
|
|
cancer | APC | A*01:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| RSDSGQQARY | - | 4°C | |||||
|
|
TS-M561-2 |
H-2Db hPSA Tetramer-HCIRNKSVIL-APC |
|
||||
|
|
cancer | APC | H-2Db | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| HCIRNKSVIL | 65-74 | 4°C | |||||
|
|
TB-M070-2 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KVLEYVIKV | 278-286 | 4°C | |||||
|
|
TB-0015-2 |
T-Select HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KIFGSLAFL | 369-377 | 4°C | |||||
|
|
TS-M095-1 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| SLLPAIVEL | 402-410 | 4°C | |||||
|
|
TS-M115-2 |
HLA-A*02:01 hTERT Tetramer-ILAKFLHWL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| ILAKFLHWL | 540-548 | 4°C | |||||
|
|
TS-M119-2 |
HLA-A*02:01 PRAME142-151 Tetramer-SLYSFPEPEA-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| SLYSFPEPEA | 142-151 | 4°C | |||||
|
|
TS-M109-2 |
HLA-B*07:02 P2X5 Tetramer-TPNQRQNVC-APC |
|
||||
|
|
cancer | APC | B*07:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TPNQRQNVC | 110-118 | 4°C | |||||
|
|
TB-0014-2 |
T-Select HLA-A*02:01 gp100 (wild) Tetramer-ITDQVPFSV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ITDQVPFSV | 209-217 | 4°C | |||||
|
|
TS-M136-1 |
HLA-A*24:02 PBF A24.2 Tetramer-AYRPVSRNI-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AYRPVSRNI | 145-153 | 4°C | |||||
|
|
TS-M561-1 |
H-2Db hPSA Tetramer-HCIRNKSVIL-PE |
|
||||
|
|
cancer | PE | H-2Db | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| HCIRNKSVIL | 65-74 | 4°C | |||||
|
|
TS-M136-2 |
HLA-A*24:02 PBF A24.2 Tetramer-AYRPVSRNI-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AYRPVSRNI | 145-153 | 4°C | |||||
|
|
TS-M526-1 |
T-Select H-2Kd HER2 Tetramer-TYLPTNASL-PE |
|
||||
|
|
cancer | PE | H-2Kd | 50 tests | ￥209,000 | 1-9 | |
| TYLPTNASL | 63-71 | 4°C | |||||
|
|
TS-M014-2 |
T-Select HLA-A*24:02 modified WT1 Tetramer-CYTWNQMNL-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 | 1-9 | |
| CYTWNQMNL | 235-243 | 4°C | |||||
※在庫につきましては2024年04月16日 17時00分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、
キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について： RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。